AYTU BIOPHARMA, INC. (AYTU) Operating income 2017–2026
AYTU BIOPHARMA, INC. (AYTU) annual operating income history from SEC filings — each fiscal year as reported.
-$8.3MFY2026 · since FY2017: -$20.1M → -$8.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$8.3M | -6.2% |
| FY2025 | -$7.8M | -392.0% |
| FY2024 | -$1.6M | +90.7% |
| FY2023 | -$17.1M | +84.5% |
| FY2022 | -$109.9M | -86.7% |
| FY2021 | -$58.9M | -178.6% |
| FY2020 | -$21.1M | -25.4% |
| FY2019 | -$16.8M | +14.5% |
| FY2018 | -$19.7M | +2.1% |
| FY2017 | -$20.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AYTU financial trends
AYTU RevenueAYTU Net incomeAYTU Net marginAYTU Gross profitAYTU Gross marginAYTU Operating marginAYTU Operating cash flowAYTU Free cash flowAYTU Capital expendituresAYTU Return on equityAYTU Stock buybacksAYTU Dividends paidAYTU Total assetsAYTU Total liabilitiesAYTU Shareholders’ equityAYTU overview →